Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | GLPG | HRMY | ||
| Company | Ultragenyx Pharmaceu | Galapagos NV ADR | Harmony Biosciences Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.36 | 33.80 | 36.48 | ||
| High | 23.77 | 33.95 | 37.08 | ||
| Low | 22.43 | 33.39 | 36.10 | ||
| Latest | 22.49 | 33.52 | 36.22 | ||
| Change | -1.01 | -0.51 | -0.19 | ||
| % Change | -4.30% | -1.50% | -0.52% | ||
| Volume | 1,900,700 | 154,200 | 648,600 | ||
| 20-Day Average Volume | 4,012,295 | 118,160 | 657,105 | ||
| Previous Close | 23.50 | 34.03 | 36.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.36 | 32.96 | 37.49 | ||
| 20-Day Raw Stochastic | 24.42% | 67.57% | 31.30% | ||
| 20-Day Relative Strength | 36.15 | 57.81 | 48.29 | ||
| Weighted Alpha | -33.53 | +37.33 | -0.89 | ||
| Today's Opinion | 100% Sell | 88% Buy | 64% Buy | ||
| Previous Opinion | 100% Sell | 88% Buy | 80% Buy | ||
| Last Month's Opinion | 56% Buy | 16% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.09% since 01/09/26 | +1.24% since 01/09/26 | -6.04% since 01/09/26 | ||
| Low | 22.40 on 01/12/26 | 32.39 on 01/13/26 | 34.68 on 01/13/26 | ||
| High | 24.65 on 01/12/26 | 34.48 on 01/15/26 | 39.40 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | -34.51% since 12/16/25 | +7.85% since 12/16/25 | -6.72% since 12/16/25 | ||
| Low | 18.41 on 12/29/25 | 31.03 on 12/17/25 | 34.68 on 01/13/26 | ||
| High | 35.12 on 12/22/25 | 34.48 on 01/15/26 | 39.60 on 12/23/25 | ||
| 3-Month | |||||
| %Chg | -33.79% since 10/16/25 | -1.67% since 10/16/25 | +39.58% since 10/16/25 | ||
| Low | 18.41 on 12/29/25 | 29.81 on 11/05/25 | 25.52 on 10/20/25 | ||
| High | 39.89 on 12/08/25 | 34.62 on 10/17/25 | 40.87 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | -17.65% since 07/16/25 | +10.81% since 07/16/25 | +2.87% since 07/16/25 | ||
| Low | 18.41 on 12/29/25 | 28.78 on 07/24/25 | 25.52 on 10/20/25 | ||
| High | 39.89 on 12/08/25 | 37.78 on 10/03/25 | 40.87 on 12/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,169,790 | 2,208,968 | 2,086,127 | ||
| Shares Outstanding, K | 96,478 | 65,900 | 57,596 | ||
| Annual Sales | 560,230,000 | 298,280,000 | 714,730,000 | ||
| Annual Net Income | -569,180,000 | 80,160,000 | 145,490,000 | ||
| Last Quarter Sales | 159,930,000 | 78,990,000 | 239,460,000 | ||
| Last Quarter Net Income | -180,410,000 | -161,610,000 | 50,870,000 | ||
| 60-Month Beta | 0.15 | 0.22 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.81 on 11/04/25 | -2.47 on 04/23/25 | 0.87 on 11/04/25 | ||
| Latest Earnings Date | 02/12/26 | 02/11/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 11.45 | ||